CN1263514C - 19f标记的蒽环酮和蒽环衍生物 - Google Patents

19f标记的蒽环酮和蒽环衍生物 Download PDF

Info

Publication number
CN1263514C
CN1263514C CNB971958947A CN97195894A CN1263514C CN 1263514 C CN1263514 C CN 1263514C CN B971958947 A CNB971958947 A CN B971958947A CN 97195894 A CN97195894 A CN 97195894A CN 1263514 C CN1263514 C CN 1263514C
Authority
CN
China
Prior art keywords
amino
daunorubicin
hydroxyl
ketone
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB971958947A
Other languages
English (en)
Chinese (zh)
Other versions
CN1223592A (zh
Inventor
T·班德拉
D·法斯里
M·卡路所
J·兰森
A·苏阿拉托
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CN1223592A publication Critical patent/CN1223592A/zh
Application granted granted Critical
Publication of CN1263514C publication Critical patent/CN1263514C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44—Naphthacenes; Hydrogenated naphthacenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CNB971958947A 1996-06-26 1997-06-18 19f标记的蒽环酮和蒽环衍生物 Expired - Fee Related CN1263514C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9613433.3A GB9613433D0 (en) 1996-06-26 1996-06-26 Fluoro labelled anthracyclinone and anthracycline derivatives
GB9613433.3 1996-06-26

Publications (2)

Publication Number Publication Date
CN1223592A CN1223592A (zh) 1999-07-21
CN1263514C true CN1263514C (zh) 2006-07-12

Family

ID=10795944

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB971958947A Expired - Fee Related CN1263514C (zh) 1996-06-26 1997-06-18 19f标记的蒽环酮和蒽环衍生物

Country Status (22)

Country Link
US (1) US6103700A (es)
EP (1) EP0910415B1 (es)
JP (1) JP2000514784A (es)
KR (1) KR100451685B1 (es)
CN (1) CN1263514C (es)
AR (1) AR008616A1 (es)
AT (1) ATE266427T1 (es)
AU (1) AU726935B2 (es)
BR (1) BR9710857A (es)
CA (1) CA2258630A1 (es)
DE (1) DE69729092D1 (es)
EA (1) EA002203B1 (es)
GB (1) GB9613433D0 (es)
HU (1) HUP9903651A3 (es)
IL (1) IL127465A (es)
NO (1) NO318194B1 (es)
NZ (1) NZ333660A (es)
PL (1) PL190149B1 (es)
TW (1) TW494099B (es)
UA (1) UA66344C2 (es)
WO (1) WO1997049433A1 (es)
ZA (1) ZA975629B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805082D0 (en) * 1998-03-10 1998-05-06 Pharmacia & Upjohn Spa Heterocyclyl anthracyclinone derivatives
GB9805080D0 (en) * 1998-03-10 1998-05-06 Pharmacia & Upjohn Spa Amino anthracyclinone derivatives
US6589504B1 (en) 2000-09-22 2003-07-08 Pharmacia & Upjohn Company Compounds and methods for diagnosing and treating amyloid-related conditions
US6828347B2 (en) 2002-11-06 2004-12-07 Illinois Institute Of Technology Anti-viral multi-quinone compounds and regiospecific synthesis thereof
EP2584369A1 (en) * 2011-10-17 2013-04-24 Koninklijke Philips Electronics N.V. Magnetic field probe for MRI with a fluoroelastomer or a solution of a fluorine-containing compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1573037A (en) * 1977-05-05 1980-08-13 Farmaceutici Italia Anthracyclines
GB1573036A (en) * 1977-05-05 1980-08-13 Farmaceutici Italia Anthracyclines
US4345070A (en) * 1980-09-29 1982-08-17 Farmitalia Carlo Erba S.P.A. Process for the preparation of 4'-deoxy-daunorubicin and 4'-deoxy-doxorubicin
GB9114549D0 (en) * 1991-07-05 1991-08-21 Erba Carlo Spa Mono and bis alkylamino-anthracyclines
GB9416007D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Anthracyclinone derivatives
GB9418260D0 (en) * 1994-09-09 1994-10-26 Erba Carlo Spa Anthracycline derivatives
WO1997016191A1 (en) * 1995-11-02 1997-05-09 Warner-Lambert Company Inhibition of amyloidosis by 9-acridinones

Also Published As

Publication number Publication date
PL330907A1 (en) 1999-06-07
US6103700A (en) 2000-08-15
KR100451685B1 (ko) 2004-12-30
HUP9903651A2 (hu) 2000-03-28
EP0910415A1 (en) 1999-04-28
ZA975629B (en) 1998-01-30
PL190149B1 (pl) 2005-11-30
CN1223592A (zh) 1999-07-21
AR008616A1 (es) 2000-02-09
IL127465A0 (en) 1999-10-28
UA66344C2 (en) 2004-05-17
KR20000022236A (ko) 2000-04-25
NZ333660A (en) 2000-07-28
EP0910415B1 (en) 2004-05-12
NO985928D0 (no) 1998-12-17
IL127465A (en) 2005-11-20
AU3262297A (en) 1998-01-14
EA002203B1 (ru) 2002-02-28
WO1997049433A1 (en) 1997-12-31
HUP9903651A3 (en) 2000-05-29
BR9710857A (pt) 1999-08-17
NO318194B1 (no) 2005-02-14
AU726935B2 (en) 2000-11-23
DE69729092D1 (de) 2004-06-17
NO985928L (no) 1998-12-17
GB9613433D0 (en) 1996-08-28
ATE266427T1 (de) 2004-05-15
EA199900054A1 (ru) 1999-06-24
JP2000514784A (ja) 2000-11-07
TW494099B (en) 2002-07-11
CA2258630A1 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
CN1022411C (zh) 含氮环状配合物的制备方法
CN1240701C (zh) 用作5HT2C激动剂的2,3,4,4a－四氢－1H－吡嗪并(1,2－a)喹喔啉－5(6H)酮衍生物
CN1225459C (zh) 具有抗炎、止痛和抗血栓形成活性的硝基氧基衍生物
CN1105558C (zh) 2,2－二氯烷羧酸、它们的制备方法、含有它们的药物以及它们在治疗耐胰岛素性中的应用
CN1202107A (zh) 选择性β3肾上腺素兴奋剂
CN1195519C (zh) 5－HT再摄取抑制剂与h5－HT1B拮抗剂或部分激动剂的组合物
CN1234738A (zh) 奥氮平二水合物d
CN1688544A (zh) 作为蕈毒碱受体拮抗剂的含氟代和磺酰氨基的3,6－二取代的氮杂双环(3.1.0)己烷衍生物
CN1047078A (zh) 用作兴奋性基酸神经递质拮抗物和/或钙通道阻滞剂的聚胺和多肽
CN1867552A (zh) 用于淀粉样蛋白积聚性疾病的探针、用于染色淀粉样蛋白的试剂、用于治疗或预防淀粉样蛋白积聚性疾病的药物、以及用于诊断神经原纤维缠结的探针以及用于染色神经原纤维缠结的试剂
CN1173964C (zh) 新型苯并呋喃酮衍生物及其制备方法
CN1111986A (zh) 治疗肠应激综合症的异噁唑衍生物
CN1108657A (zh) 雪花胺衍生物、其制备方法及其作为药物的用途
CN1200699C (zh) 蒽酮衍生物及其在淀粉样变性中的用途
CN1278727A (zh) 单胺氧化酶抑制剂和h5－ht1B拮抗剂或部分激动剂的组合
CN1079957A (zh) 可用于射线照相法对照产物的化合物
CN85107496A (zh) 制备四氢化萘衍生物的方法
CN1263514C (zh) 19f标记的蒽环酮和蒽环衍生物
CN1105990A (zh) 苯基链烷醇胺衍生物
CN1930179A (zh) 糖链配体络合物和利用该配体络合物的蛋白质的分析方法
CN1024790C (zh) 尿素衍生物及其盐的制备方法
CN1099752A (zh) 新型酰氨烷基-和亚氨烷基-哌嗪
CN1191241C (zh) 用于抗充血性心力衰竭的哒嗪基苯基腙
CN1060769C (zh) 1，4-苯并嗪衍生物，含该化合物的药物组合物及其用途
CN1052865A (zh) 新的蒽环型药类及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1020315

Country of ref document: HK

C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee